{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:47:30Z","timestamp":1791283650537,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.neurobiolaging.2005.05.025","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T11:12:51Z","timestamp":1124190771000},"page":"770.e1-770.e5","source":"Crossref","is-referenced-by-count":39,"title":["Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Roberto","family":"Del Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scarlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Martinelli-Boneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1126\/science.1087348","article-title":"Games played by rogue proteins in prion disorders and Alzheimer's disease","volume":"302","author":"Aguzzi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-003-0700-7","article-title":"Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing","volume":"106","author":"Berr","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.51.3.734","article-title":"Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study","volume":"51","author":"Berr","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2003.11.018","article-title":"The current status of Alzheimer's disease genetics: what do we tell the patients?","volume":"50","author":"Bertram","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.71.2.279","article-title":"Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?","volume":"71","author":"Casadei","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-V","article-title":"Genetic predisposition to iatrogenic Creutzfeldt\u2013Jakob disease","volume":"337","author":"Collinge","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000058332","article-title":"Candidate gene association studies in sporadic Alzheimer's disease","volume":"14","author":"Combarros","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.55.4.593","article-title":"Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD","volume":"55","author":"Combarros","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.10658","article-title":"Early cognitive decline is associated with prion protein codon 129 polymorphism","volume":"54","author":"Croes","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-510X(96)00249-3","article-title":"The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects","volume":"145","author":"Del Bo","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00415-003-1057-5","article-title":"The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects","volume":"250","author":"Del Bo","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.20390","article-title":"VEGF gene variability is associated with increased risk for Alzheimer's disease","volume":"57","author":"Del Bo","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","article-title":"PRNP Vall29 homozygosity increases risk for early-onset Alzheimer's disease","volume":"53","author":"Dermaut","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004010000271","article-title":"Prion protein expression in senile plaques in Alzheimer's disease","volume":"101","author":"Ferrer","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/01.WNL.0000103290.74549.DC","article-title":"Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD","volume":"62","author":"Golanska","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neurobiolaging.2004.07.003","article-title":"Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients","volume":"26","author":"Guidi","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004010050870","article-title":"Coexistence of Alzheimer-type neuropathology in Creutzfeldt\u2013Jakob disease","volume":"96","author":"Hainfellner","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/WNL.54.8.1641","article-title":"Neuropathologic variants of sporadic Creutzfeldt\u2013Jakob disease and codon 129 of PrP gene","volume":"54","author":"Hauw","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib20","doi-asserted-by":"crossref","unstructured":"McNeill A. Comment on \u201cThe codon 129 polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects\u201d\u2014by Del Bo et al. in J Neurol 2003;250:688\u201392. J Neurol 2004;251:892\u20133.","DOI":"10.1007\/s00415-004-0457-5"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1083320","article-title":"Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics","volume":"300","author":"Mead","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1600-0404.2003.00199.x","article-title":"The normal population distribution of PRNP codon 129 polymorphism","volume":"108","author":"Nurmi","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.10748","article-title":"Absence of association between codon 129\/219 polymorphisms of the prion protein gene and Alzheimer's disease in Japan","volume":"54","author":"Ohkubo","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt\u2013Jakob disease","volume":"352","author":"Palmer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib25","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1073\/pnas.97.18.10168","article-title":"Genetic influence on the structural variations of the abnormal prion protein","volume":"97","author":"Parchi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","article-title":"Prion protein codon 129 polymorphism and risk of Alzheimer disease","volume":"63","author":"Riemenschneider","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.mp.4001327","article-title":"Ml29V variation in the prion protein may influence cognitive performance","volume":"8","author":"Rujescu","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2005.05.025_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s004010100405","article-title":"Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases","volume":"101","author":"Voigtlander","year":"2001","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T01:49:55Z","timestamp":1586396995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458005001612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0197458005001612"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.05.025","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}